Merck Financial Statements From 2010 to 2024

MRK Stock  USD 101.64  1.48  1.44%   
Merck financial statements provide useful quarterly and yearly information to potential Merck Company investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merck financial statements helps investors assess Merck's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck's valuation are summarized below:
Gross Profit
42.1 B
Profit Margin
0.1923
Market Capitalization
257.1 B
Enterprise Value Revenue
4.5018
Revenue
63.2 B
There are currently one hundred twenty fundamental ratios for Merck that can be evaluated and compared over time across peers in the industry. We recommend to check Merck's last-minute fundamental drivers against the all of the trends between 2010 and 2024. Market Cap is expected to rise to about 268.6 B this year. Enterprise Value is expected to rise to about 296.4 B this year

Merck Total Revenue

32.37 Billion

Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 B, Interest Expense of 1.2 B or Total Revenue of 32.4 B, as well as many indicators such as Price To Sales Ratio of 4.32, Dividend Yield of 0.0246 or PTB Ratio of 6.92. Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
Check out the analysis of Merck Correlation against competitors.

Merck Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets60.3 B106.7 B89.7 B
Pretty Stable
Short and Long Term Debt Total38.1 B36.3 B25.5 B
Slightly volatile
Other Current Liabilities18.3 B17.5 B13.4 B
Slightly volatile
Total Current Liabilities13.3 B25.7 B19.1 B
Slightly volatile
Total Stockholder Equity25.5 B37.6 B36.9 B
Pretty Stable
Property Plant And Equipment Net25.7 B24.5 B15.8 B
Slightly volatile
Retained Earnings32.6 B53.9 B42.4 B
Slightly volatile
Cash5.6 B6.8 B8.7 B
Pretty Stable
Non Current Assets Total41.1 B74.5 B61.5 B
Pretty Stable
Cash And Short Term Investments7.3 B7.1 B11 B
Slightly volatile
Net Receivables10.9 B10.3 B7.5 B
Slightly volatile
Common Stock Shares Outstanding2.7 B2.5 B2.7 B
Slightly volatile
Liabilities And Stockholders Equity60.3 B106.7 B89.7 B
Pretty Stable
Non Current Liabilities Total45.5 B43.3 B34.8 B
Slightly volatile
Inventory3.7 B6.4 B5.3 B
Pretty Stable
Other Current Assets8.8 B8.4 B5.3 B
Slightly volatile
Total Liabilities72.5 B69 B54.8 B
Slightly volatile
Total Current Assets19.2 B32.2 B28.2 B
Pretty Stable
Short Term Debt2.3 B1.7 B2.9 B
Very volatile
Intangible Assets14.3 B18 B18.5 B
Pretty Stable
Accounts Payable2.8 B3.9 BB
Slightly volatile
Property Plant And Equipment Gross43.4 B41.3 B20.7 B
Slightly volatile
Common Stock Total Equity1.2 B2.1 B1.6 B
Slightly volatile
Capital Stock1.2 B2.1 B1.6 B
Slightly volatile
Common Stock1.2 B2.1 B1.6 B
Slightly volatile
Other Liabilities10.2 B10.5 B10.9 B
Slightly volatile
Other Assets5.5 B8.5 BB
Slightly volatile
Long Term Debt17.2 B33.7 B21.5 B
Slightly volatile
Good Will12.3 B21.2 B16.1 B
Slightly volatile
Property Plant Equipment16.2 B24.6 B15.8 B
Slightly volatile
Current Deferred Revenue6.6 B5.3 B2.3 B
Slightly volatile
Long Term Debt Total23.6 B33.1 B22.6 B
Slightly volatile
Capital Surpluse44.7 B51 B41.6 B
Slightly volatile
Long Term Investments239.4 M252 M5.7 B
Slightly volatile
Short and Long Term Debt1.3 B1.4 B2.2 B
Slightly volatile
Non Current Liabilities Other10.8 B8.8 B9.3 B
Slightly volatile
Cash And Equivalents9.3 B14.6 B8.1 B
Slightly volatile
Net Invested Capital69.2 B72.6 B61.4 B
Slightly volatile
Net Working Capital6.3 B6.5 B5.9 B
Very volatile

Merck Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.8 B3.9 B4.7 B
Slightly volatile
Total Revenue32.4 B60.1 B42.4 B
Slightly volatile
Gross Profit46.2 B44 B30.1 B
Slightly volatile
Other Operating Expenses60 B57.2 B36.3 B
Slightly volatile
Operating Income5.6 BB6.2 B
Slightly volatile
EBIT5.6 BB6.1 B
Slightly volatile
EBITDA8.4 B6.9 B10.8 B
Slightly volatile
Cost Of Revenue11.7 B16.1 B14 B
Pretty Stable
Total Operating Expenses43 B40.9 B21.9 B
Slightly volatile
Income Before Tax1.8 B1.9 B8.2 B
Very volatile
Net Income346.8 M365 M6.3 B
Pretty Stable
Income Tax ExpenseB1.5 BB
Very volatile
Research Development32.1 B30.5 B11.9 B
Slightly volatile
Selling General Administrative8.7 B8.2 B9.3 B
Slightly volatile
Net Income Applicable To Common Shares17.5 B16.7 B8.8 B
Slightly volatile
Net Income From Continuing OpsB4.6 B7.7 B
Very volatile
Non Recurring288.1 M303.3 M787.3 M
Slightly volatile
Selling And Marketing Expenses2.2 B2.3 B7.1 B
Slightly volatile
Tax Provision2.2 B2.8 B1.7 B
Slightly volatile
Interest Income732.6 M390 M776.1 M
Pretty Stable
Reconciled Depreciation3.1 B3.8 B4.2 B
Slightly volatile
Discontinued Operations563.2 M633.6 M689.9 M
Slightly volatile

Merck Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow6.7 B9.1 B8.3 B
Slightly volatile
Begin Period Cash Flow13.4 B12.8 B9.6 B
Pretty Stable
Depreciation3.1 B3.9 B4.7 B
Slightly volatile
Capital Expenditures2.2 B3.9 B2.6 B
Slightly volatile
Total Cash From Operating Activities8.8 B13 B10.8 B
Slightly volatile
Net Income346.8 M365 M6.1 B
Very volatile
End Period Cash Flow6.2 B6.9 B8.8 B
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.324.72813.7988
Slightly volatile
Dividend Yield0.02460.02620.0321
Slightly volatile
PTB Ratio6.927.56314.9377
Slightly volatile
Days Sales Outstanding67.4462.83663.3101
Pretty Stable
Book Value Per Share7.7814.435313.5197
Very volatile
Free Cash Flow Yield0.04170.03220.0511
Slightly volatile
Operating Cash Flow Per Share2.564.98863.9679
Slightly volatile
Stock Based Compensation To Revenue0.00710.01070.0082
Slightly volatile
Capex To Depreciation1.360.99770.7749
Slightly volatile
PB Ratio6.927.56314.9377
Slightly volatile
EV To Sales3.275.21764.0417
Slightly volatile
Free Cash Flow Per Share1.933.50693.0143
Slightly volatile
ROIC0.00770.00810.0777
Pretty Stable
Inventory Turnover3.452.53632.6473
Pretty Stable
Net Income Per Share0.130.142.3326
Pretty Stable
Days Of Inventory On Hand160144144
Pretty Stable
Payables Turnover4.274.11174.8582
Slightly volatile
Sales General And Administrative To Revenue0.180.13650.1778
Slightly volatile
Research And Ddevelopement To Revenue0.530.50790.2455
Slightly volatile
Capex To Revenue0.07140.06430.0602
Slightly volatile
Cash Per Share2.092.72063.9462
Pretty Stable
POCF Ratio18.1121.853816.2487
Slightly volatile
Interest Coverage2.452.57778.5022
Very volatile
Payout Ratio21.4220.39733.5191
Slightly volatile
Capex To Operating Cash Flow0.30.2970.2483
Slightly volatile
PFCF Ratio25.9531.087222.4236
Slightly volatile
Days Payables Outstanding12288.771593.7528
Very volatile
Income Quality37.4135.63296.3907
Slightly volatile
ROE0.00920.00970.1776
Very volatile
EV To Operating Cash Flow18.9924.116417.6142
Slightly volatile
PE Ratio818779128
Slightly volatile
Return On Tangible Assets0.00510.00540.1104
Very volatile
EV To Free Cash Flow27.234.305824.3208
Slightly volatile
Earnings Yield0.00120.00130.0401
Slightly volatile
Intangibles To Total Assets0.210.36750.3455
Pretty Stable
Current Ratio1.621.2521.5546
Slightly volatile
Receivables Turnover4.985.80885.8101
Very volatile
Graham Number6.46.738424.8618
Very volatile
Shareholders Equity Per Share7.2414.414613.2872
Very volatile
Debt To Equity0.980.93280.6951
Slightly volatile
Capex Per Share1.561.48171.0157
Slightly volatile
Revenue Per Share24.2123.057816.48
Slightly volatile
Interest Debt Per Share14.5813.88539.7419
Slightly volatile
Debt To Assets0.350.32860.2635
Slightly volatile
Enterprise Value Over EBITDA47.6845.411617.0367
Slightly volatile
Short Term Coverage Ratios6.09.47965.4633
Pretty Stable
Price Earnings Ratio818779128
Slightly volatile
Operating Cycle227207208
Very volatile
Price Book Value Ratio6.927.56314.9377
Slightly volatile
Days Of Payables Outstanding12288.771593.7528
Very volatile
Dividend Payout Ratio21.4220.39733.5191
Slightly volatile
Price To Operating Cash Flows Ratio18.1121.853816.2487
Slightly volatile
Price To Free Cash Flows Ratio25.9531.087222.4236
Slightly volatile
Pretax Profit Margin0.02990.03140.1936
Pretty Stable
Ebt Per Ebit1.060.63951.8163
Slightly volatile
Operating Profit Margin0.04670.04910.1382
Pretty Stable
Effective Tax Rate0.840.80040.3188
Slightly volatile
Company Equity Multiplier1.92.83852.4668
Slightly volatile
Long Term Debt To Capitalization0.50.47270.3595
Slightly volatile
Total Debt To Capitalization0.510.48260.3931
Slightly volatile
Return On Capital Employed0.03470.03650.0913
Pretty Stable
Debt Equity Ratio0.980.93280.6951
Slightly volatile
Ebit Per Revenue0.04670.04910.1382
Pretty Stable
Quick Ratio0.941.00451.2341
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.61.15021.4143
Pretty Stable
Net Income Per E B T0.180.19320.6818
Slightly volatile
Cash Ratio0.330.26620.4823
Slightly volatile
Cash Conversion Cycle85.51118130
Slightly volatile
Operating Cash Flow Sales Ratio0.20.21640.2458
Pretty Stable
Days Of Inventory Outstanding160144144
Pretty Stable
Days Of Sales Outstanding67.4462.83663.3101
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.580.7030.7437
Slightly volatile
Cash Flow Coverage Ratios0.350.3710.6211
Slightly volatile
Price To Book Ratio6.927.56314.9377
Slightly volatile
Fixed Asset Turnover2.162.45492.8094
Pretty Stable
Capital Expenditure Coverage Ratio3.483.36684.7037
Slightly volatile
Price Cash Flow Ratio18.1121.853816.2487
Slightly volatile
Enterprise Value Multiple47.6845.411617.0367
Slightly volatile
Debt Ratio0.350.32860.2635
Slightly volatile
Cash Flow To Debt Ratio0.350.3710.6211
Slightly volatile
Price Sales Ratio4.324.72813.7988
Slightly volatile
Return On Assets0.00330.00340.0707
Pretty Stable
Asset Turnover0.730.56350.5035
Pretty Stable
Net Profit Margin0.00580.00610.1452
Pretty Stable
Gross Profit Margin0.740.73170.6744
Slightly volatile
Price Fair Value6.927.56314.9377
Slightly volatile
Return On Equity0.00920.00970.1776
Very volatile

Merck Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap268.6 B255.8 B188 B
Slightly volatile
Enterprise Value296.4 B282.3 B206.5 B
Slightly volatile

Merck Fundamental Market Drivers

Forward Price Earnings10.6383
Cash And Short Term Investments7.1 B

Merck Upcoming Events

25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Merck Financial Statements

Merck investors utilize fundamental indicators, such as revenue or net income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.3 B6.6 B
Total Revenue60.1 B32.4 B
Cost Of Revenue16.1 B11.7 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.14  0.18 
Research And Ddevelopement To Revenue 0.51  0.53 
Capex To Revenue 0.06  0.07 
Revenue Per Share 23.06  24.21 
Ebit Per Revenue 0.05  0.05 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Dividend Share
3.04
Earnings Share
4.78
Revenue Per Share
24.931
Quarterly Revenue Growth
0.044
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.